Search Results
Results found for "Heptares Therapeutics"
- đ° GPCR Weekly News, February 12 to 18, 2024
Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 Sosei Heptares
- Ever Wondered How Drugs Are Discovered?
How do molecules make the leap from laboratory concept to therapeutic reality? miss the forest for the trees The critical importance of translation âturning lab data into meaningful therapeutic
- GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors
diabetes to cancer, fibrosis, and CNS disorders â GPCRs  are at the heart of the worldâs most pressing therapeutic Class in Drug Discovery GPCRs regulate countless physiological processes, making them a goldmine for therapeutic But the real  excitement is in whatâs next: Biased signaling  for selective therapeutic effects. Orphan GPCRs  with untapped therapeutic potential. youâre in early discovery or clinical development, the strategies here could open doors in your own therapeutic
- How GPCR Spatial Signaling Sparked a Scientific Journey
For innovators building tools, platforms, or therapeutics, these origin moments are where tomorrowâs receptors control localised signaling, how disease hijacks these systems, and how to target them for therapeutic Her work sits at the intersection of fundamental biology and therapeutic strategy. Knowing where  signals occur could unlock new therapeutic strategies, better efficacy, and fewer side
- Profiling Immune Cell and Platelet Transcriptomes
signaling, influencing a wide array of physiological processes and serving as critical targets for therapeutic significant findings that enhance our understanding of GPCRs' roles in immune function and potential therapeutic macrophages suggest that these GPCRs could be targeted to modulate inflammatory responses, offering potential therapeutic the field continues to evolve, the insights gained from this research will be instrumental in shaping therapeutic
- Understanding Orthosteric Binding: The Key to Drug Action
This foundational knowledge guides researchers in the development of new therapeutics. It can inform decisions in drug design, improving therapeutic outcomes and reducing unwanted side effects This understanding can enhance your appreciation for drug development and therapeutic action.
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
and the complexity of the central nervous system (CNS) pose a challenge for developing successful therapeutics Emerging GPCR Therapeutic Targets in CNS Drug Discovery GPCRs have been studied for decades, but there Of the traditional GPCRs, CBRs are gaining ground as potential therapeutic targets in several CNS diseases One of the best tools to study therapeutic targets are fluorescent ligands , which are very useful in G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative
- From Switches to Microcircuits: GPCR Biased Signaling and the Future of Drug Discovery
Ligands designed to activate therapeutically beneficial pathways, while avoiding those associated with The therapeutic logic is sound: if signaling pathways are separable, they are potentially selectable. Family C), adhesion GPCRs, and Frizzled receptors (Family VI) have all attracted growing interest as new therapeutic both been implicated in COVID-19 pathophysiology â and represent active targets for receptor-directed therapeutic provides the needed mechanistic depth to define the functional selectivity  that may ultimately determine therapeutic
- Inside Out: Mapping GPCRs from Membrane Codes to Market Moves
Selection  â Master GPCR behavior beyond second messengers  Build sharper strategies for GPCR-targeted therapeutics receptor biologyâand how theyâre being used to de-orphanize GPCRs, explore autoantibodies, and uncover new therapeutic
- New Podcast, Sweet Structures & $2.2B GPCR Moves
mGluR2, and a big headline, Novo Nordiskâs $2.2B deal with Septerna to develop GPCR-targeted obesity therapeutics Biased signalling of Class B G protein-coupled receptor-targeted therapeutics . Â
- đ° GPCR Weekly News, September 4 to 10, 2023
Our partner, Domain Therapeutics, will attend the SACHS 23rd annual biotech event in Europe. Dr. Christopher Langmead and colleagues' work on the 5-HT2C receptor as a therapeutic target for substance GPCR Symposium on ''GPCRs as Therapeutic Modalities' Share your project with a 1-minute abstract video Protein and Exendin-P5 Biased Agonist Molecular and structural insights into the 5-HT2C receptor as a therapeutic teams up with addiction treatment maker Indivior to make digital therapeutics for substance use disorders
- Enhancing GPCR Research Outreach | Dr GPCR University early-bird registration ends soon!
for Drug Discovery DMS: Linking Protein Structure To Function AbbVie Completes Acquisition of Cerevel Therapeutics Nxera Pharma attended the Drug Discovery Ecosystem Summit Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as Concurrent Private Placement of $130.7 Million Tectonic Therapeutic Announces
- GPCR Internalization: When the Signal Moves Inside the Cell
the cell depends on the ligandâreceptor complex â and that distinction has direct implications for therapeutic Recycling Versus Degradation: The CCR5 Example The therapeutic stakes of this distinction are illustrated logic, the mechanistic distinctions, and the interpretive frameworks that connect trafficking data to therapeutic
- Dr. GPCR and Celtarys Research Join Forces to Expand Access to Innovative GPCR Tools
Celtarysâ cutting-edge fluorescent ligand technology and accelerate the development of GPCR-targeted therapeutics accelerate the adoption of our chemical tools and foster collaborations that turn receptor biology into therapeutic
- GPCR Buzz of the Week | Sep 23 - 29, 2024
November 7th : Drug Disposition in Physiological Tissues as a Therapeutic Variable. December 5th : Unique Exploitable GPCR-Ligand Behaviors for Therapeutic Benefit. Generate:Biomedicines Announces Multi-Target Collaboration with Novartis to Discover and Develop Protein Therapeutics with SEP-786, a Novel Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism Confo Therapeutics a Complex Between an Antibody-based Agonist and a Class A GPCR Regulating Hunger and Satiety OMass Therapeutics
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
This approach reveals: Hidden target overlap New therapeutic hypotheses âOff-targetâ effects that may This reroutes discovery toward: Functionally selective ligands Better therapeutic windows More predictable What matters now is not the category , but the fit: Does the chemical matter support the therapeutic
- đ° GPCR Weekly News, December 11 to 17, 2023
This week's highlights: Kudos to our partner, GPCR Therapeutics, for partnering with Bridge Biotherapeutics acids conjugation with [Cp*Rh(H2O)3]2+ by using the meta-dynamics/FMO3 approach Industry News GPCR Therapeutics - Providing the next generation of high-impact medicines Structure Therapeutics Provides Comprehensive Study Neurocrine opening two Phase 1 trials in oral Parkinsonâs therapies Bearing Fruit: Deep Apple Therapeutics Launches to Screen AI-Generated Virtual Libraries AbbVie to Acquire Cerevel Therapeutics in Transformative
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⌿ Oct 28 - Nov 3, 2024
et al. for their fantastic review on Molecular and structural insights into the 5-HT2C receptor as a therapeutic IPO to $331m Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR- Targeted Antibody Therapeutics Using Generative AI Zombie Fungi Hijack Hostsâ Brains GPCR Therapeutics, Inc. has received Orphan Drug 20th World Congress of Basic and Clinical Pharmacology GPCR Jobs Scientist I Cell Biology - Tectonic Therapeutic proteins in obesity and diabetes mellitus Molecular and structural insights into the 5-HT2C receptor as a therapeutic
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
not just the pancreas This tool helped clarify: Which neurons respond Which cell populations drive therapeutic metabolic therapy Guide how next-generation incretin drugs are designed Support cell-targeted conjugate therapeutic
- Sweet taste receptor agonists attenuate macrophage ILâ1β expression and eosinophilic inflammation...
Eosinophilic inflammation is a hallmark of refractory chronic rhinosinusitis (CRS) and considered a major therapeutic (ECRS) via macrophage ILâ1β overproduction, thereby suggesting autophagy regulation as a potential therapeutic We sought to investigate the therapeutic potential of autophagyâenhancing agent, trehalose, or related Methods We investigated the therapeutic effects of trehalose and saccharin on macrophage ILâ1β production
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
That choice determines whether you risk over- or under-dosing, miss safety windows, or miss therapeutic More nuanced control, fewer off-target liabilities, and novel therapeutic windows. Correctly distinguishing these mechanisms helps refine therapeutic index calculations, prioritize safer
- GPCR Happy Hour Boston 2026 â April 29 | Dr. GPCR Community Event
Whether you're decoding signaling pathways or designing the next generation of therapeutics, Revvity includes over 1,000 functional assays representing more than 550 GPCR and other targets, trusted by therapeutic
- Why Sokhom Pin Never Left GPCRs, Even When Everyone Else Did
Advances in biased signaling, allosterism, and endosomal signaling have opened new therapeutic frontiers
- đ° GPCR Weekly News, June 12 to 18, 2023
GPCRs in Neuroscience Orphan receptor GPR88 as a potential therapeutic target for CNS disorders - an Industry News Coherus to Acquire Surface Oncology Confo Therapeutics and AbCellera partner on GPCR-targeting Patent in Japan Proteros Biostructures GmbH Revolutionizes Metabolic Disorder Treatments Structure Therapeutics (June 28 - 30, 2023) NEW FREE Seminar Antibodies targeting Membrane Proteins - From Antigen to New Therapeutics
- From Ox Liver to AI: How the History of Pharmacology Shapes Its Future
đ Join Terryâs Corner, your essential launchpad into the world of therapeutic science Unlock "The History
- Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research
GPCRs are one of the most important families of therapeutic targets in the pharmaceutical industry molecular binding mechanism behind C5a and C5aR interaction is crucial for developing novel immunological therapeutics fluorescent probes have proven to be optimal tools to perform fluorescence-based assays to unlock the therapeutic Function, Structure and Therapeutic Potential of Complement C5a Receptors.
- Adenosine receptor signalling in Alzheimer's disease
Emerging evidence suggests adenosine G protein-coupled receptors (GPCRs) are promising therapeutic targets In this review, we provide an accessible summary of the literature on Alzheimer's disease and the therapeutic allosterism and the targeting of oligomers, which may increase drug discovery success and enhance the therapeutic
- Adenosine receptor signalling in Alzheimer's disease
Emerging evidence suggests adenosine G protein-coupled receptors (GPCRs) are promising therapeutic targets In this review, we provide an accessible summary of the literature on Alzheimer's disease and the therapeutic allosterism and the targeting of oligomers, which may increase drug discovery success and enhance the therapeutic
- GPCR Happy Hour â Boston, Sept 2025
delivers cutting-edge imaging and analysis that accelerates the discovery of new and life-changing therapeutics comprehensive approach enables Axxam to support clients worldwide in identifying and optimizing new therapeutic
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
Discovery on Targetâs 19th Annual GPCR-Based Drug Discovery Targeting G Protein-Coupled Receptors for New Therapeutic Industry News MBX aims for $136M IPO to take potential rival to Ascendis' Yorvipath into phase 3 Certa Therapeutics proteins for biology and health research Innovate UK announced the winners of its Transforming Cancer Therapeutics






















